Tumor accumulation of Abraxane® is favored by the overexpression of the secreted protein acidic and rich in cysteine (SPARC) in the membrane of the tumor cell, associated with albumin arrest in the microenvironment [109]. The gene discussed is SPARC; the disease is neoplasm.